Mutations responsible for 3-phosphoserine phosphatase deficiency

  • Eur J Hum Genet. 2004 Feb;12(2):163-6. doi: 10.1038/sj.ejhg.5201083.
Maria Veiga-da-Cunha  1 Jean-François Collet Benoît Prieur Jaak Jaeken Yves Peeraer Anja Rabbijns Emile Van Schaftingen
Affiliations
  • 1. 1Laboratory of Physiological Chemistry, Institute of Cellular Pathology (ICP) and Université catholique de Louvain, Brussels, Belgium.
Abstract

We report the identification of the mutations in the only known case of L-3-phosphoserine Phosphatase deficiency, a recessively inherited condition. The two mutations correspond to the replacement of the semiconserved Asp32 residue by an asparagine and of the extremely conserved Met52 by a threonine. The effects of both mutations were studied on the human recombinant enzyme, expressed in Escherichia coli. Met52Thr almost abolished the enzymatic activity, whereas the Asp32Asn mutation caused a 50% decrease in Vmax. In addition, L-serine, which inhibits the conversion of [(14)C] phosphoserine to serine when catalysed by the wild-type enzyme, had a lesser inhibitory effect on the Asp32Asn mutant, indicating a reduction in the rate of phosphoenzyme hydrolysis. These modifications in the properties of the enzyme are consistent with the modification in the kinetic properties observed in fibroblasts from the patient.